Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,135,040
  • Shares Outstanding, K 477,558
  • Annual Sales, $ 5,825 M
  • Annual Income, $ 1,428 M
  • 60-Month Beta 0.86
  • Price/Sales 9.92
  • Price/Cash Flow 31.72
  • Price/Book 24.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.88
  • Number of Estimates 6
  • High Estimate 0.91
  • Low Estimate 0.87
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +6.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
119.52 +2.56%
on 09/16/19
130.08 -5.77%
on 09/09/19
-2.79 (-2.23%)
since 08/16/19
3-Month
110.72 +10.71%
on 06/18/19
130.08 -5.77%
on 09/09/19
+11.77 (+10.62%)
since 06/17/19
52-Week
78.90 +55.36%
on 12/24/18
130.08 -5.77%
on 09/09/19
+34.28 (+38.82%)
since 09/17/18

Most Recent Stories

More News
Zoetis Inc Falls 1.03% on Heavy Volume: Watch For Potential Rebound

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $119.71 to a high of $120.50. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $120.03...

ZTS : 122.42 (+2.32%)
Small Drug Stock Outlook: Innovation Holds the Key to Growth

Small Drug Stock Outlook: Innovation Holds the Key to Growth

VRCA : 14.80 (-0.07%)
LCI : 13.77 (+2.46%)
GALT : 3.56 (+2.59%)
ZTS : 122.42 (+2.32%)
Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year?

Is (ZTS) Outperforming Other Medical Stocks This Year?

ZTS : 122.42 (+2.32%)
Uptrend Call Working As Zoetis Inc Stock Rises 19.9% (ZTS)

SmarTrend identified an Uptrend for Zoetis Inc (NYSE:ZTS) on May 3rd, 2019 at $102.59. In approximately 4 months, Zoetis Inc has returned 19.92% as of today's recent price of $123.03.

ZTS : 122.42 (+2.32%)
Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting

Zoetis Inc. today announced that its scientists presented positive efficacy data for the company's investigational, triple combination parasiticide product at the 2019 Triennial meeting of the American...

ZTS : 122.42 (+2.32%)
Zoetis Inc Set to Possibly Rebound After Yesterday's Selloff of 1.61%

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $126.20 to a high of $130.00. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $126.58...

ZTS : 122.42 (+2.32%)
Why Is Zoetis (ZTS) Up 5.5% Since Last Earnings Report?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZTS : 122.42 (+2.32%)
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

AMT : 221.30 (+2.09%)
IVV : 302.71 (+0.24%)
ZTS : 122.42 (+2.32%)
SPY : 300.92 (+0.25%)
AMGN : 196.72 (+1.36%)
FTCS : 57.44 (+0.45%)
Zoetis to Participate in the Bank of America Merrill Lynch Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 19, 2019, in London, England. Clint Lewis, Executive Vice President and Group...

ZTS : 122.42 (+2.32%)
Zoetis Inc Shares Up 23.9% Since SmarTrend's Buy Recommendation (ZTS)

SmarTrend identified an Uptrend for Zoetis Inc (NYSE:ZTS) on May 3rd, 2019 at $102.59. In approximately 4 months, Zoetis Inc has returned 23.94% as of today's recent price of $127.15.

ZTS : 122.42 (+2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 121.19
1st Resistance Point 120.41
Last Price 122.42
1st Support Level 119.19
2nd Support Level 118.75

See More

52-Week High 130.08
Last Price 122.42
Fibonacci 61.8% 110.53
Fibonacci 50% 104.49
Fibonacci 38.2% 98.45
52-Week Low 78.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar